Dyląg Katarzyna Anna, Skowron Kamil Paweł, Kurnik-Łucka Magdalena, Drzewiecki Łukasz, Przybyszewska Katarzyna, Król-Dykas Magdalena, Dumnicka Paulina, Gawlik Zuzanna, Gawlik Jakub, Sikora Sebastian, Gil Krzysztof
Department of Pathophysiology, Jagiellonian University Medical College, 31-121 Krakow, Poland.
St. Louis Children Hospital, 31-503 Krakow, Poland.
Nutrients. 2024 Nov 28;16(23):4112. doi: 10.3390/nu16234112.
Anorexia nervosa (AN) is a psychiatric disorder with a high mortality rate and significant prevalence in the paediatric population. Preliminary reports during the COVID-19 pandemic suggested an increased incidence of AN among children and adolescents. The objective of this study was to analyse new cases of AN before, during, and after the pandemic, with a particular focus on the physical manifestations of the disease.
This single-centre, retrospective study included new AN cases from the hospital database of a regional paediatric hospital (a reference centre for AN) between 2013 and 2023. Data analysed included the duration of the disease, body mass index (BMI), weight loss, length of hospitalisation, laboratory markers (leukopenia, anaemia, hypoproteinaemia, hyperferritinaemia, hypophosphataemia, dyslipidaemia, and hypothyroxinaemia) and clinical features of malnutrition (such as amenorrhea bradycardia, pericardial effusion, and cortical/subcortical atrophy).
This study was conducted in a Polish regional hospital. We analysed 228 hospitalized female patients aged 10 to 18 years diagnosed with AN, focusing on clinical characteristics, biochemical markers, and the impact of the COVID-19 pandemic. The COVID-19 pandemic was shown to have a significant impact, with longer hospitalisations observed during and after the pandemic and a lower BMI on admission post-pandemic compared to pre-pandemic. In addition, nutritional treatment became more prevalent over time while biochemical markers such as anaemia, hypothyroidism, hypophosphataemia, and dyslipidaemia were statistically more common post-pandemic.
This study demonstrates a significant impact of the COVID-19 pandemic on the clinical course and hospitalisation patterns of paediatric patients with AN. These findings suggest that the pandemic may have exacerbated disease severity and altered treatment approaches, emphasizing the need for enhanced clinical management and follow-up strategies for AN in the paediatric population during such health crises.
神经性厌食症(AN)是一种在儿科人群中死亡率高且患病率显著的精神疾病。新冠疫情期间的初步报告表明,儿童和青少年中AN的发病率有所上升。本研究的目的是分析疫情前、疫情期间和疫情后的AN新病例,特别关注该疾病的身体表现。
这项单中心回顾性研究纳入了2013年至2023年间一家地区儿科医院(AN参考中心)医院数据库中的AN新病例。分析的数据包括疾病持续时间、体重指数(BMI)、体重减轻、住院时间、实验室指标(白细胞减少、贫血、低蛋白血症、高铁蛋白血症、低磷血症、血脂异常和低甲状腺素血症)以及营养不良的临床特征(如闭经、心动过缓、心包积液和皮质/皮质下萎缩)。
本研究在波兰一家地区医院进行。我们分析了228名年龄在10至18岁之间被诊断为AN的住院女性患者,重点关注临床特征、生化指标以及新冠疫情的影响。结果显示,新冠疫情产生了重大影响,疫情期间和疫情后住院时间更长,且疫情后入院时的BMI低于疫情前。此外,随着时间的推移,营养治疗变得更加普遍,而贫血、甲状腺功能减退、低磷血症和血脂异常等生化指标在疫情后在统计学上更为常见。
本研究表明,新冠疫情对患有AN的儿科患者的临床病程和住院模式产生了重大影响。这些发现表明,疫情可能加剧了疾病的严重程度并改变了治疗方法,强调在此类健康危机期间,需要加强对儿科人群中AN的临床管理和随访策略。